Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

830.95INR
3:43pm IST
Change (% chg)

Rs-25.65 (-2.99%)
Prev Close
Rs856.60
Open
Rs851.00
Day's High
Rs858.45
Day's Low
Rs828.00
Volume
143,132
Avg. Vol
283,972
52-wk High
Rs1,200.70
52-wk Low
Rs706.40

SUN.BO

Chart for SUN.BO

About

Sun Pharmaceutical Industries Limited is an India-based generic and pharmaceutical company. The Company's business segments include US Business, which includes Western Europe, Canada, Australia, New Zealand and Other Markets; Indian Branded Generics Business, including Global Consumer Healthcare Business, and Emerging Markets,... (more)

Overall

Beta: 0.39
Market Cap(Mil.): Rs2,059,505.00
Shares Outstanding(Mil.): 2,406.67
Dividend: 3.00
Yield (%): 0.35

Financials

  SUN.BO Industry Sector
P/E (TTM): 66.84 31.28 37.85
EPS (TTM): 12.80 -- --
ROI: 13.44 14.74 14.09
ROE: 11.45 15.31 14.83
Search Stocks

BUZZ-India's Sun Pharma gains as Kotak says FDA warning issues not major

** Shares in India's Sun Pharmaceuticals Industries Ltd rose as much as 3.4 percent on Wednesday morning to a high of 790 rupees

23 Dec 2015

BUZZ-India's Sun Pharma gains after aborting wind energy investment

** Announcement allays capital allocation concerns of investors - Analysts

26 Nov 2015

BUZZ-Indian drug makers attract short positions despite being oversold

** Indian drug makers attract short positions in derivatives even after being oversold

10 Nov 2015

BUZZ-India's Sun Pharma slumps; CSuisse cuts on higher chances of warning on Halol

** Says new disclosure of Halol being classified as official action initiated (OAI) flag increases the chances of a warning letter

09 Nov 2015

BUZZ-Indian drug makers slump; US FDA scrutiny, weak earnings weigh

** Sun Pharmaceutical Industries slumps 5.3 pct, Dr.Reddy's Laboratories down 1.7 pct and Lupin falls 1.6 pct

09 Nov 2015

BUZZ-India's Sun Pharma gains on hopes for US drug for Taro unit

** Traders cite optimism tied to launch of Keveyis drug in the U.S. market by unit Taro Pharmaceutical Industries

14 Sep 2015

Sun Pharma looking to divest Ireland plant

MUMBAI Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said it is looking to divest a manufacturing plant in Ireland as it tries to control costs that have spiralled since it bought Ranbaxy Laboratories Ltd.

10 Sep 2015

REFILE-India's Sun Pharma looking to divest Ireland plant

MUMBAI, Sept 10 Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said it is looking to divest a manufacturing plant in Ireland as it tries to control costs that have spiralled since it bought Ranbaxy Laboratories Ltd.

10 Sep 2015

BRIEF-India's Sun Pharma says receives USFDA nod for ximino

* Says USFDA approved supplemental new drug application for ximino extended-release capsules 45 mg, 90 mg and 135 mg Source text for Eikon: http://bit.ly/1hMr5DX Further company coverage:

19 Aug 2015

BUZZ-India's Sun Pharma gains after BofA-ML upgrade

** Cites integration with Ranbaxy, price hikes at unit Taro and improvement in US supplies as key reason for the upgrade

19 Aug 2015

Earnings vs. Estimates

Search Stocks